Vanguard Personalized Indexing Management
LNAI

Vanguard Personalized Indexing Management’s Lunai Bioworks LNAI Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio LNAI Stock Details LNAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-314
Closed -$13.6K – 2022
2025
Q1 		$13.6K Buy
314
+55
+21% +$3.52K ﹤0.01% 1813
2024
Q4 		$17.3K Sell
259
-20
-7% -$1.33K ﹤0.01% 1775
2024
Q3 		$10.8K Buy
+279
New +$19.3K ﹤0.01% 1759

Other funds holding LNAI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Vanguard Personalized Indexing Management's LNAI Position: Q2 2025 in Review

Vanguard Personalized Indexing Management sold out of Lunai Bioworks (LNAI) in Q2 2025, closing a stake of 314 shares — an estimated $13.6K sold.

Vanguard Personalized Indexing Management first reported a position in LNAI in Q3 2024 and held it in 3 quarters. The position peaked at $17.3K in Q4 2024. 42 funds tracked by Wall St. Rank hold LNAI as of Q2 2025.

  • Vanguard Personalized Indexing Management reported no remaining Lunai Bioworks position as of Q2 2025 after selling out during the quarter.
  • Vanguard Personalized Indexing Management sold 314 Lunai Bioworks shares in Q2 2025, an estimated $13.6K.
  • Vanguard Personalized Indexing Management first reported a position in Lunai Bioworks in Q3 2024 and held it in 3 quarters.
  • Vanguard Personalized Indexing Management's Lunai Bioworks position peaked at $17.3K in Q4 2024.
  • 42 funds tracked by Wall St. Rank held Lunai Bioworks as of Q2 2025.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2025, filed 25 Jul 2025.